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Abstract
Purpose To diagnose cholesteatoma when it is not visible through tympanic perforation, imaging techniques are necessary. 
Recently, the combination of computed tomography and magnetic resonance imaging has proven effective to diagnose mid-
dle ear cholesteatoma. In particular, diffusion weighted images have integrated the conventional imaging for the qualitative 
assessment of cholesteatoma. Accordingly, the aim of this study was to obtain a quantitative analysis of cholesteatoma 
calculating the apparent diffusion coefficient value. So, we investigated whether it could differentiate cholesteatoma from 
other inflammatory tissues both in a preoperative and in a postoperative study.
Methods This study included 109 patients with clinical suspicion of primary or residual/recurrent cholesteatoma. All patients 
underwent preoperative computed tomography and magnetic resonance imaging with diffusion sequences before primary or 
second-look surgery to calculate the apparent diffusion coefficient value.
Results We found that the apparent diffusion coefficient values of cholesteatoma were significantly lower than those of non 
cholesteatoma. In particular, the apparent diffusion coefficient median value of the cholesteatoma group (0.84 × 10− 3 mm2/s) 
differed from the inflammatory granulation tissue (2.21 × 10− 3 mm2/s) group (p < 2.2 × 10− 16). Furthermore, we mod-
eled the probability of cholesteatoma by means of a logistic regression and we determined an optimal cut-off probability 
value of ~ 0.86 (specificity = 1.0, sensitivity = 0.97), corresponding to an apparent diffusion coefficient cut-off value of 
1.37 × 10− 3 mm2/s.
Conclusions Our study has demonstrated that apparent diffusion coefficient values constitute a valuable quantitative param-
eter for preoperative differentiation of cholesteatomas from other middle ear inflammatory diseases and for postoperative 
diagnosis of recurrent/residual cholesteatomas.
Keywords Cholesteatoma · Granulation tissue · Middle ear · Magnetic resonance imaging · Apparent diffusion coefficient 
(ADC).
Introduction
Cholesteatoma is a middle ear lesion consisting of squamous 
cells debris. It is locally aggressive and requires surgical 
treatment. Imaging techniques are needed when cholestea-
toma is not visible through a tympanic perforation.
Computed tomography (CT) has proven to be very useful 
for evaluating the extent of the disease and visualizing ear 
landmarks. However, it can only provide indirect signs of 
cholesteatoma like bone erosion of crucial anatomical areas 
(e.g., tegmen tympani, scutum, and ossicular chain), show-
ing low values of sensitivity (43%) and specificity (48%) for 
recurrent or residual cholesteatoma [1].
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Recently, the combination of CT and Magnetic Reso-
nance Imaging (MRI) has remarkably improved the diagnos-
tic accuracy of cholesteatoma. Conventional cholesteatoma 
MRI images per se only display non-specific intermediate 
signal intensities on T1-weighted imaging and hyperin-
tense signal intensities on T2-weighted imaging without 
significant enhancement [2, 3]. More recently, the Diffu-
sion Weighted Intensity (DWI)-MRI has thus integrated the 
conventional MRI to assess the nature of middle ear lesions 
[3–6]. However, the DWI-MRI technique represents only a 
qualitative evaluation tool, depending on the subjective eval-
uation of experienced radiologists [7]. Prior studies on quali-
tative DWI has showed high values of sensitivity, specificity, 
positive predictive values (PPV) and negative predictive val-
ues (NPV) for echo-planar (EPI) and non echo-planar (non-
EPI) sequences as reported in systematic reviews written by 
Jindal et al. [8] and Muzaffar et al. [9]. Recently, reported 
ranges for EPI sequences are: sensitivity of 12.5–100%, 
specificity of 60–100%, PPV of 80–100%, NPV of 50–92%. 
Instead, reported ranges for non-EPI sequences are: sensitiv-
ity of 62–100%, specificity of 85.7–100%, PPV of 89–100%, 
NPV of 50–100% [9].
The purpose of this study was to perform a quantitative 
analysis of middle ear cholesteatoma. For this purpose, we 
applied the apparent coefficient diffusion (ADC) protocol 
to DWI-MRI to identify a numeric cut-off value that could 
differentiate cholesteatoma from other inflammatory tissue 
both in a preoperative and in a postoperative study, in a large 
sample size.
Materials and methods
Participants
This prospective study—carried out at the University 
of Naples “Federico II” (Naples, Italy) from April 2011 
to March 2016—included 109 consecutive patients (62 
females; 47 males; age range 10–70 years, mean age 
35.6 years) with clinical suspicion of primary or residual/
recurrent cholesteatoma.
Exclusion criteria were formal contraindications in per-
forming MRI or patients’ refusal to undergo MRI.
In our study, all patients underwent preoperative CT 
examination and MRI imaging of the petrous temporal bone 
within 1–2 weeks after CT examination, before primary or 
second-look surgery. Intraoperative observations, which 
established the presence of cholesteatoma and/or granu-
lation tissue, were subsequently confirmed histologically. 
Cholesteatoma was confirmed in 77 (70.64%) cases, whereas 
granulation tissue was found in 32 (29.36%) cases. Fifty-
eight subjects (53.21%), i.e., 38 (65.52%) with cholestea-
toma and 20 (34.48%) with granulation tissue, underwent 
primary tympanoplasty; whereas 51 (46.79%) subjects, 39 
(76.47%) with cholesteatoma and 12 (23.53%) with granula-
tion tissue underwent second-look surgery. The mean ADC 
value, measured on the ADC map, was calculated on the 
basis of the DWI sequences obtained before surgery.
All participants gave their written informed consent to 
participate in the study, which was fully approved by the 
local Board of Medical Ethics.
Imaging
The CT examination, required routinely for all patients 
undergoing surgery, has been performed by the Toshiba 
Aquilion 64-slice equipment.
MRI examination was performed on a 1.5T MR unit 
(Philips Intera, Philips Medical Systems, ++Netherlands) 
with an 8-channel head coil. Conventional sequences and 
Multi–Shot Non-Echo Planar Diffusion Weighted Imag-
ing (MSh non-EPI DWI − 20 slides; TR 3000  ms; TE 
82.44 ms; matrix 160 × 160; voxel size 2338 × 1210; b = 0 
and b = 1000 s/mm2; 5 averages) were obtained on the cor-
onal plane. In particular, DWI acquisition was performed 
with cardiac gating to limit patient-related artifacts. ADC 
maps were then obtained with the Osirix plugin “ADC Map 
Calculation”; the ADC value was calculated by placing a 
small region of interest (ROI) of 1 mm2 in the part of the 
lesion with more evident water diffusion restriction. Our 
choice to use an ROI with a small diameter was dictated 
by the small size of the lesions considered and by the need 
to obtain numerical ADC values that could actually reflect 
cholesteatomas, thus minimizing the interference of sur-
rounding tissues.
Whether ADC could differentiate cholesteatoma from 
other inflammatory tissue was established by the arithmetic 
mean of ADC values measured by three different neurora-
diologists, respectively, 30 years-long (E.A.), 15 years-long 
(R.C.) and 5 years-long experience (B.L.) in head and neck 
imaging. Our radiologists were blinded in terms of surgical 
findings.
Statistical analysis
The distribution of ADC mean values of patients with his-
tologically confirmed cholesteatoma was compared with 
that of patients with non-cholesteatomatous inflammatory 
lesions by means of Wilcoxon rank-sum test. A binomial 
logistic regression model was used to predict the probability 
of cholesteatoma and inflammation on the basis of the ADC 
values. In particular, a 10-fold cross-validation approach was 
used to assess the mean accuracy of the model and a final 
logistic model was trained on the whole dataset (average 
accuracy: 0.96, SD = 0.07).
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To determine an optimal cut-off on the probability value, 
Youden’s J statistic was applied to the ROC curve of the 
estimated probabilities—which were obtained by applying 
the computed logistic function to the 109 starting values. In 
general, the optimal cut-off is determined as the threshold 
that maximizes the distance to the identity (diagonal) line. 
A p value of 0.01 was considered statistically significant.
All statistical analyses were performed with R version 
3.2.5 software (cit. R Core Team: R: A Language and Envi-
ronment for Statistical Computing, R Foundation for Statisti-
cal Computing, Vienna, Austria: ISBN 3-900051-07-0, URL 
http://www.R-proje ct.org/).
Results
We analyzed the distribution pattern of ADC values of 
a cholesteatoma and a granulation tissue group. The two 
groups were characterized by different ADC values (Fig. 1). 
Statistically strong differences in ADC values were found 
between cholesteatoma (median 0.84 × 10− 3  mm2/s) and 
granulation tissue (median 2.21 × 10− 3  mm2/s) (Wilcoxon 
rank-sum test, p = 4.88 × 10− 16) (Fig. 2).
Binomial logistic regression (intercept = 12.352, beta 
= − 7.647) estimated the probability of cholesteatoma vs 
granulation tissue on the basis of the ADC values. An ROC 
Fig. 1  The scatter plot represents the distribution of the ADC values 
between cholesteatoma and granulation tissue samples. There are 
three outliers: two false positive cases (FP) (number 14 and 66) and a 
false negative patient (FN) (number 93) (black arrows). Moreover two 
other patients resulted borderline (BL) (number 20 and 63). (unfilled 
circle: patient with cholesteatoma underwent tympanoplasty, filled 
circle: patient with cholesteatoma that underwent second-look sur-
gery, unfilled triangle: patient with granulation tissue that underwent 
tympanoplasty, filled triangle: patient with granulation tissue that 
underwent second-look surgery)
Fig. 2  The box plot represents 
the distribution pattern of ADC 
values of a cholesteatoma and 
a granulation tissue group. The 
two groups were characterized 
by different ADC values: cho-
lesteatoma (median 0.84 × 10− 3 
 mm2/s) and granulation tissue 
(median 2.21 × 10− 3  mm2/s)
(Wilcoxon rank-sum test, 
p = 4.88 × 10− 16). + (positive for 
cholesteatoma); − (negative for 
cholesteatoma)
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curve evaluated the estimated probabilities, yielding an opti-
mal cut-off value for the probability value of ~ 0.86 (speci-
ficity = 1.0 sensitivity = 0.97). This value corresponded to 
a cut-off ADC value of 1.37 × 10− 3 mm2/s (Fig. 3). This 
value corresponds the best threshold value that can be used 
to classify patients with cholesteatoma based on the trained 
regression model.
Moreover, according to the class-probability values pro-
vided by our model we could identify three outliers in our 
original dataset: two false positive cases (number 14 and 
66) and a false negative patient (number 93). Moreover, 
two other patients resulted borderline (number 20 and 63) 
(Figs. 1, 2, 3).
Discussion
According to many authors [3–5, 10], DWI-MRI provides 
greater accuracy in differentiating cholesteatoma from other 
types of middle ear inflammation than standard CT, espe-
cially in second-look surgery. In fact, although CT scans are 
indeed valuable tools, they do show low diagnostic accuracy. 
For instance, Ganaha et al. [11], who evaluated the sensi-
tivity and reliability of CT scans in detecting cholesteato-
mas, found that CT scans can provide accurate sensitivity, 
specificity, positive predictive values and negative predictive 
values only up to 71.1%, 78.5%, 93.3%, 39.2%, respectively.
Similarly, the sensitivity of echo planar DWI is highly 
variable, ranging from 12.5 to 86% [12, 13]. For instance, 
a study comprising 100 patients (55 primary cases with 
acquired cholesteatoma and 45 with residual cholestea-
toma) reports a sensitivity rate of 81% for primary acquired 
cholesteatomas and 12.5% for residual cholesteatomas [12]. 
Very recent research further suggests the rather low and 
variable reliability of these sequences, reporting sensitivity, 
specificity, positive and negative predictive values of 86%, 
87%, 92%, 77%, respectively [14]. The main limitation of 
echo-planar DWI sequences seems to be attributable to their 
inability to detect small cholesteatomas (< 5 mm) [15].
Contrary to echo-planar DWI, non-echo planar DWI 
appears more efficient in detecting cholesteatomas owing to 
its ability to detect cholesteatomas as small as 3 mm [13]. A 
recent systematic review of 8 studies with 207 subjects cor-
roborates the higher reliability of non-planar DWI sequences 
by reporting a 91% sensitivity and 96% specificity for recur-
rent and residual cholesteatomas [8].
Overall, although these radiological images provide 
meaningful clinical information, their interpretation still 
remains rather subjective (Figs. 4, 5). Accordingly, the 
experience of neuroradiologists are paramount to inter-
pret MRI imaging and to achieve accurate diagnosis of 
cholesteatomas.
To overcome these limitations and obtain a more com-
plete, quantitative analysis of middle ear lesions, we applied 
the apparent coefficient diffusion (ADC) protocol to identify 
a numeric cut-off value that could differentiate cholestea-
toma from inflammatory tissue especially after second-look 
surgeries. Indeed, after these types of surgical procedures 
a suspect lesion is more difficult to investigate both micro-
scopically and otoendoscopically because of the recon-
structed eardrum integrity.
So far, only few studies have underscored the importance 
of combining ADC values with DWI-MRI to differentiate 
with greater specificity cholesteatoma from other inflam-
matory diseases of the middle ear [16]. However, the small 
sample of these studies has been a major limitation [2].
To the best of our knowledge, this study embraces the 
largest sample size ever reported in the literature on the com-
bination of DWI and estimated ADC values to differentiate 
cholesteatoma from other middle ear inflammatory diseases.
Fig. 3  Logistic model to predict 
the probability of patho-
logical state (cholesteatoma or 
granulation tissue) given the 
ADC value. Optimal cut-off 
ADC value corresponded 
to 1.37 × 10− 3 mm2/s (black 
arrow). (unfilled circle: patient 
with cholesteatoma underwent 
tympanoplasty, filled circle: 
patient with cholesteatoma that 
underwent second-look surgery, 
unfilled triangle: patient with 
granulation tissue that under-
went tympanoplasty, filled tri-
angle: patient with granulation 
tissue that underwent second-
look surgery, FP false positive 
cases, FN false negative cases, 
BL borderline cases)
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We found significant differences in ADC values between 
cholesteatoma and granulation tissue. This finding is sup-
ported by previous literature reporting that ADC values in 
cholesteatoma are significantly lower than those in other 
middle ear inflammatory diseases [7, 16].
In addition, using the logistic regression model, we 
were able to calculate an optimal ADC cut-off value 
(1.37 × 10− 3 mm2/s) to identify patients with cholestea-
toma. This allowed us to identify cholesteatomas from the 
ADC values below our cut-off value with a high diagnos-
tic accuracy (specificity = 1.0 sensitivity = 0.97). Remark-
ably, we misdiagnosed only three patients. In particular, we 
found one false negative and two false positive cases. The 
false negative was due to the small size of the cholestea-
toma (< 3 mm)—as it was too small to be detected by DWI, 
even using non-EPI Multi-Shot (MSh) sequences [3, 17, 18]. 
Instead, the false positive patients were due to the presence 
of a superinfection, which generally decreases ADC values, 
as evidenced in a previous study reporting low ADC values 
in cases of middle ear abscess [2].
Conclusion
Despite the imbalanced nature of our sample—as it 
included more cholesteatomatous cases than non-choleste-
atomatous ones—we have demonstrated that ADC values 
can provide a quantitative analysis of cholesteatoma even 
if it is not visible through tympanic perforation. DWI dis-
played significantly lower ADC values for cholesteatoma 
Fig. 4  Axial SE-T1w (a), axial TSE-T2w (b), coronal MSH-TSE 
DWI (c) with the calculated ADC value on ADC cartography (area: 
1.000 mm2; W: 1.000 mm × H: 1.000 mm; mean: 639 × 10− 6 mm2/s; 
min: 339 × 10− 6 mm2/s; max: 791 × 10− 6 mm2/s) (d) of a 40 year-old 
male patient with final diagnosis of right middle ear primary choles-
tatoma
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(median 0.84 × 10− 3 mm2/s) than for noncholesteatoma-
tous tissue (median 2.21 × 10− 3 mm2/s). This finding sug-
gests that the combination of a qualitative evaluation of 
DWI sequences andADC values can increase the diagnos-
tic accuracy even of small-sized cholesteatomas, especially 
in post-operative follow-up cholesteatomas. In particular, 
our estimated ADC cut-off value of 1.37 × 10− 3 mm2/s 
allowed us to identify cholesteatoma from ADC values 
lower than our cut-off value with a high diagnostic accu-
racy (specificity = 1.0 sensitivity = 0.97).
Technological advances are nonetheless warranted to 
overcome one major shortcoming in this field of research: 
the limited sensitivity of current imaging techniques in 
detecting cholesteatomas less than 3 mm.
Compliance with ethical standards 
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Fig. 5  Axial SE-T1w (a), axial TSE-T2w (b), coronal MSH-
TSE DWI (c) with the calculated ADC value on ADC car-
tography (area: 1.000  mm2; W: 1.000  mm × H: 1.000  mm; 
mean: 2277 × 10 − 6  mm2/s; min: 2203 × 10 − 6  mm2/s; max: 
2341 × 10 − 6mm2/s) (d) of a 53 year-old female patient with final 
diagnosis of right middle ear non-cholesteatomatous granulation tis-
sue
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